You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Pentamidine isethionate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for pentamidine isethionate and what is the scope of patent protection?

Pentamidine isethionate is the generic ingredient in four branded drugs marketed by Fresenius Kabi Usa, Seton Pharms, X-gen Pharms Inc, Armour Pharm, Avet Lifesciences, Baxter Hlthcare, Hospira, Watson Labs, and Xgen Pharms, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are thirteen drug master file entries for pentamidine isethionate. Four suppliers are listed for this compound.

Summary for pentamidine isethionate
Drug Prices for pentamidine isethionate

See drug prices for pentamidine isethionate

Recent Clinical Trials for pentamidine isethionate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Mayo ClinicPhase 1
University of Texas Southwestern Medical CenterPhase 1
National Institute on Alcohol Abuse and Alcoholism (NIAAA)Phase 1

See all pentamidine isethionate clinical trials

Pharmacology for pentamidine isethionate
Drug ClassAntiprotozoal
Medical Subject Heading (MeSH) Categories for pentamidine isethionate

US Patents and Regulatory Information for pentamidine isethionate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira PENTAMIDINE ISETHIONATE pentamidine isethionate INJECTABLE;INJECTION 073479-001 Jun 30, 1992 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs PENTAMIDINE ISETHIONATE pentamidine isethionate INJECTABLE;INJECTION 074303-001 Aug 17, 1995 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Baxter Hlthcare PENTAMIDINE ISETHIONATE pentamidine isethionate INJECTABLE;INJECTION 073617-001 Dec 18, 1995 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.